PHARMACY PRACTICE-V (CLINICAL
PHARMACY-I) (Theory)
Paper 2 Marks 100
1.
GENERAL INTRODUCTION TO CLINICAL
PHARMACY:
a.
Introduction to clinical
pharmacy and related terms, definition, basic components, comparison with other
clinical fields, scope of services.
b.
Guidelines (General guidelines
for Clinical Pharmacy Practice)
c.
Patient counseling compliance
d.
Laboratory Data interpretation
e.
Electrolytes management
f.
Clinical literature evaluation
g.
Drug interactions
h.
Medication errors
2.
DISEASE MANAGEMENT:
Disease management should be
covered by considering aspects like diseases definition, etiology, pathogenesis,
clinical presentation, diagnostic work out (briefly), pharmacotherapy.
MODULES:
• Unit I: Cardiovascular unit (hypertension, ischemic heart diseases e.g. angina pectoris, MI,
Heart failure).
• Unit II: Pulmonary unit (Asthma e.g. acute, chronic, status asthamaticus, childhood asthma,
Pneumonia, COPD includes emphysema & chronic bronchitis)
• Unit III: Gastroenterology unit [ulcer, liver cirrhosis, portal hypertension, hepatitis, diarrhea,
inflammatory bowel disease (IBD)].
3.
PATIENT PROFILE & PATIENT
COUNSELING:
a.
Patient disease profile
b.
Taking case history
c.
Drug profile of at least 25
Important Medications e.g. Adrenaline, Aminoglycosides, Anti-TB Drugs,
Antiepileptics, Atropine, Benzodiazepines, Cepahlosporins, Chlorpheniramine, Cimetidine,
Digoxin, Dobutamine, Dopamine, Fluroquinolone, Furosemide, Lactulose,
Macrolides, Metoclopramide, Morphine/Pethedine, Nifedipine, NSAIDS, ORS,
Penicillins, Prednisolone, Salbutamol, Vancomycin.
d.
Patient Counseling
4.
CLINICAL TRIALS OF DRUG SUBSTANCES: Designing of clinical trials, types of
trials, Choice of patients, exclusion of patients and monitoring a clinical
trial.
5.
EMERGENCY TREATMENT: For example, Cardiopulmonary
resuscitation (CPR), Cold Blue.
6.
DRUG INTERACTIONS: Mechanism, Physiological factors affecting interaction, Types and
level of drug interactions, Role of pharmacist in evaluating drug interaction
& its management.
7.
PHARMACOVIGILANCE:
a.
Scope, definition and aims of
Pharmacovigilance
b.
Adverse Drug Reactions and Side
Effects: Classification, Excessive pharmacological response, Idiosyncrasy,
Secondary pharmacological effects, Allergic drug reactions, Detection,
Management of ADR, reporting of ADR in light of international health monitoring
system.
8.
PHARMACOTHERAPY PLAN:
I. Development, Implementation and Monitoring of Drug
Therapy Plans:
a.
Pharmacist work up of drug
therapy (PWDT)
b.
Documentation of
Pharmacotherapy Plan
• SOAP note
• CORE Pharmacotherapy Plan
• PRIME Pharmacotherapy problems
• FARM note
c.
Implementation of Drug Therapy
Plan
d.
Monitoring of
Pharmacotherapeutic plan
e.
Pharmaceutical care plan as
ongoing process
f.
Importance of drug therapy plan
in today’s pharmacy practice
II. Pharmacotherapy Decision-Making:
A.
Pursue the role of drug therapy
practitioner over that of drug therapy advisor.
B.
Participate in pharmacotherapy
decision-making by:
a.
Identifying opportunities
for decision-making.
b.
Proactively engaging
decision-making opportunities.
c.
Formulating decision
rationale that is the result of rigorous inquiry, scientific reasoning, and
evidence.
d.
Pursuing the highest levels
of decision-making.
e.
Seeking independence in
making decisions and accepting personal responsibility for the outcomes to patients
resulting from one’s decisions.
f.
Personally enacting
decisions
9.
DRUG INDUCED DISEASES:
10. UTILIZATION OF CLINICAL DRUG LITERATURE: Introduction, Drug literature selection, Drug literature evaluation
and Drug literature communication.
11. ONLINE PHARMACEUTICAL CARE SERVICES AND GLOBALIZATION:
12. PROVISION OF PHARMACEUTICAL CARE IN MULTIPLE ENVIRONMENTS:
Comments
Post a Comment